Galectin Therapeutics Plans Adaptively Designed Phase 3 NASH-RX Clinical Trial in NASH CirrhosisGlobeNewsWire • 12/05/19
Merck's Keytruda + Galectin's Belapectin (GR-MD-02): Thoughts On The EvidenceSeeking Alpha • 04/17/19